Drug Information

Drug General Information
Drug ID
D08KBV
Former ID
DNC012650
Drug Name
4-Biphenyl-4-yl-2-cyclohexylmethyl-1H-imidazole
Drug Type
Small molecular drug
Indication Discovery agent Investigative [527102]
Formula
C22H24N2
Canonical SMILES
C1CCC(CC1)CC2=NC=C(N2)C3=CC=C(C=C3)C4=CC=CC=C4
InChI
1S/C22H24N2/c1-3-7-17(8-4-1)15-22-23-16-21(24-22)20-13-11-19(12-14-20)18-9-5-2-6-10-18/h2,5-6,9-14,16-17H,1,3-4,7-8,15H2,(H,23,24)
InChIKey
LAHDQEJNOQBNSA-UHFFFAOYSA-N
PubChem Compound ID
9966703
Target and Pathway
Target(s) Voltage-gated sodium channel subunit alpha Nav1.3 Target Info Inhibitor [527102]
Sodium channel Target Info Inhibitor [527102]
KEGG Pathway Dopaminergic synapse
Reactome Interaction between L1 and AnkyrinsR-HSA-445095:Interaction between L1 and Ankyrins
References
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.
Ref 527102Bioorg Med Chem Lett. 2004 Jul 5;14(13):3521-3.2-Alkyl-4-arylimidazoles: structurally novel sodium channel modulators.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.